SEC Tracker
Get the app

MetaVia MTVA

MetaVia announces trial data acceptance

Item 7.01 Investor disclosure

Form
8-K
Filed
Importance
Routine
  1. Phase 1 trial data for DA-1726 accepted
  2. Oral presentation at Precision Liver Symposium 2026
  3. Event scheduled for November 4, 2026

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when MetaVia files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Oragenics OGEN public float $3M, Jun 30, 2025
  2. Inhibitor Therapeutics INTI public float $3M, Jun 30, 2025
  3. PTC Therapeutics PTCT public float $3M, Jun 30, 2025
  4. Propanc Biopharma PPCB public float $3M, Dec 31, 2025
  5. Integrated Biopharma INBP public float $3M, Dec 31, 2025